Mail icon

Future-Proofing The Aseptic Drug Manufacturing Process

13 December, 2021 | ChargePoint Technology

With the aseptic drug manufacturing market rapidly expanding, it is important that CDMOs find methods to increase output of end products whilst also complying with the increasingly stringent regulatory challenges around sterile containment. This is especially important as the demand for their services increases rapidly. In this article, Christian Dunne, our Head of Sterile Solutions, discusses the adoption of single-use technology as well as the implementation of “smart” factory technology and how these technologies can increase efficiency as well as ensure aseptic integrity.

 

Read the full article here: https://issuu.com/senglobal1/docs/2021-ipi-autumn-web_compressed_a77846c5d0060c

Related articles